Modulation of systemic cytokine levels by implantation of alginate encapsulated cells
- 15 April 1994
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 170 (2) , 185-196
- https://doi.org/10.1016/0022-1759(94)90394-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prevention of lethal graft‐vs.‐host disease by a single low dose injection of anti‐T cell monoclonal antibody to the allograft recipientsEuropean Journal of Immunology, 1991
- Continuous Production of Monoclonal Antibody by Hybridoma Cells Immobilized in Hardened Alginate Gel ParticlesAnnals of the New York Academy of Sciences, 1990
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990
- Techniques for Mammalian Cell ImmobilizationNature Biotechnology, 1988
- Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectorsEuropean Journal of Immunology, 1988
- Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.The Journal of Experimental Medicine, 1987
- [33] First-strand cDNA synthesis primed with oligo(dT)Published by Elsevier ,1987
- Physical Studies on Cell Immobilization Using Calcium Alginate GelsBiotechnology & Bioengineering, 1979
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Strontium–Calcium Selectivity of AlginatesNature, 1967